TCORS set to support the FDA's regulatory role: Program designed to generate tobacco‐related research to inform policy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|6|771-772

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.6, 2014-03, pp. : 771-772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicotine and angiogenesis: a new paradigm for tobacco-related diseases

By Cooke John   Bitterman Haim  

Annals of Medicine, Vol. 36, Iss. 1, 2004-01 ,pp. : 33-40

Informa Healthcare

Access to resources Recommend Favorite

Harm Reduction – A Treatment Approach for Resistant Smokers with Tobacco-Related Symptoms

By  

Respiration, Vol. 69, Iss. 5, 2002-09 ,pp. : 452-455

Karger

Access to resources Recommend Favorite

FDA funds research to help guide tobacco regulation: New tobacco products, young adult smokers, and race among focus of studies

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3751-3752

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulatory Focus: Bringing home the genome: the US FDA’s role in realizing personalized medicine

By Hamburg Margaret  

Personalized Medicine, Vol. 7, Iss. 3, 2010-05 ,pp. : 239-242

Future Medicine

Access to resources Recommend Favorite

Modernizing US regulatory and reimbursement policy to support continued innovation in genomic pathology

By Walcoff Sheila D   Pfeifer John D  

Personalized Medicine, Vol. 9, Iss. 3, 2012-05 ,pp. : 295-308

Future Medicine

Access to resources Recommend Favorite